Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $16.2100 (1.25%) ($16.2100 - $16.2100) on Mon. Mar. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.02% (three month average) | RSI | 27 | Latest Price | $16.2100(1.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.9% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.51% in a week (0% probabilities). VIXM(-34%) VXX(-27%) IGOV(-15%) UNG(-11%) TLT(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.51% (StdDev 3.02%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $1.79(-88.96%) | Inflection Point | Yes | Resistance Level | $17.57 | 5 Day Moving Average | $16.22(-0.06%) | 10 Day Moving Average | $16.53(-1.94%) | 20 Day Moving Average | $17.57(-7.74%) | To recent high | -37.3% | To recent low | 2.6% | Market Cap | $1.205b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |